Review Article
Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
Table 7
Treatment response of ocular inflammation.
| | Patient | Gender | Age | Ocular inflammation | BCVA | ACC | CFT |
| | 1 | Female | 59 | Keratitis | Pre:RE:20/200 LE:20/20
Post:RE:20/30 | Pre:RE0 | NA | | 2 | Female | 45 | Anterior and intermediate uveitis | NA | Pre:RE2+ LE2+
Post: RE0.5+ LE0 | NA | | 3 | Female | 40 | Scleritis | NA | NA | NA | | 4 | Female | 22 | Anterior uveitis | Pre:RE20/100 LE20/200
Post:RE20/25 LE20/32 | Pre:RE3+ LE0+
Post:RE0 LE0 | Pre:
RE468 LE630
Post:
RE252 LE254 | | 5 | Female | 45 | Scleritis | NA | NA | NA | | 6 | Female | 43 | Panuveitis | Pre:RE:20/40
LE:No light perception | Pre:2+
Post:0 | Pre:350
Post:270 | | 7 | Female | 18 | Panuveitis | Post:RE:20/40 LE:20/200 | Pre:3+
Post:0.5+ | Pre:320
Post:264 | | 8 | Female | 37 | Anterior uveitis | Post:RE: 20/60 LE: 20/60 | Pre:2+
Post:0 | Pre:450
Post:276 | | 9 | Male | 21 | Panuveitis | Post:RE: 20/20 LE: 20/20 | Pre:3+
Post:0.5+ | Pre:400
Post:280 | | 10 | Male | 65 | Scleritis | Pre:RE6/ 6 LE 6/36
Post:LE6/24 | Pre:1+
Post:0 | NA | | 11 | Male | 43 | Conjunctivitis | Pre:RE20/30 LE:Counting fingers | NA | NA |
|
|
Note: ACC: anterior chamber cell; BCVA: best corrected visual acuity; CFT: central foveal thickness: Pre: pretreatment; Post: posttreatment; RE: right eye; LE: left eye; NA: not available.
|
